Methods: Three focus groups consisting of family and internal medicine physicians were conducted in Pittsburgh, York, and Philadelphia, PA, using a semistructured topic guide to facilitate discussions. Each participant completed an exit survey at session conclusion.
T he high incidence of preventable adverse drug events in the ambulatory care setting has been broadly described in the literature. 1, 2 Greater access to pharmacists and enhanced collaboration between prescribers and pharmacists may prevent these events 2 and improve health outcomes. [3] [4] [5] [6] Although evidence supports physician-pharmacist collaborations, this type of coordinated care is not routinely practiced in community settings. Medication therapy management (MTM) services present an opportunity for patients and physicians to work closely with community-based pharmacists. 7 Pharmacist-provided MTM core elements include a comprehensive medication therapy review, personal medication record, medication-related action plan, intervention and/or referral, documentation, and collaboration with the patient's physician to follow-up and address all medication-related needs of the patient. 8 Some physicians are unfamiliar with a pharmacist's role in patient care beyond the provision of a drug product. [9] [10] [11] To establish collaborative relationships with physicians when providing MTM, pharmacists must understand physician needs related to patient medication regimens and their perceptions of ReseaRch Notes pharmacist-provided MTM. 12 This study uses qualitative methods to identify and explore physician perceptions of community pharmacist-provided MTM.
Methods

Design
Three physician focus groups were conducted in market research facilities in Pittsburgh, York, and Philadelphia, PA. Geographic locations were chosen to provide a diversity of participants from urban, suburban, and rural locations and were limited by facility location. Facilitators with experience leading focus groups conducted the 2-hour sessions, which were audio recorded and transcribed. The resulting text was analyzed using qualitative methods. [13] [14] [15] [16] [17] This study was approved by the University of Pittsburgh Institutional Review Board.
Participants
Family and internal medicine physicians practicing in outpatient settings in Pennsylvania were eligible for this study. Participants were randomly selected from the Pennsylvania Medical Society membership list and recruited by client service representatives from each market research facility through an initial phone call and/or facsimile and a follow-up phone call. Using a screening tool developed by study investigators, recruiters aimed for 10 to 12 physicians per group, anticipating that 8 to 10 physicians would ultimately participate based on the typical drop-out rate of market research groups. Participants who completed the study were provided a monetary incentive ranging from $175 to $200, as determined by market trends in each geographic area.
Focus group script
An MTM-trained pharmacist reviewed the core elements of MTM with each facilitator and provided a semistructured topic guide with literature-derived questions (Table 1) 8-12,18,19 and a detailed description of the community pharmacists' role in MTM. During each session, the facilitator asked participants a series of questions designed to elicit the physicans' perceived medication-related needs of their patients, determine how those needs are being met, and identify perceived benefits and concerns related to pharmacist-provided MTM. After each focus group session, the research team refined the topic guide for clarity.
Qualitative data analysis
The dialogue from each session was transcribed verbatim. Qualitative data analysis was then performed using an iterative coding process, which involves reading the data and identifying repetitive themes. [13] [14] [15] [16] [17] Coding was conducted by the principal investigator and a coder employed by the University of Pittsburgh Qualitative Data Analysis Program, using the qualitative data management software ATLAS.ti (version 5.2; AT-LAS.ti, Berlin). The codebook reflected a combined inductive/ deductive approach to analysis. After coding each transcript, the coders collaboratively refined each code definition to better apply the codes to the next round of coding and eliminate discrepancies. Repeating themes were identified and findings subsequently summarized.
exit survey
After each focus group session, participants completed an anonymous exit survey that identified past and current experience with pharmacists (Table 2 ). Five close-ended responses described varying levels of involvement in patient care. The preferred method(s) of communication with a pharmacist about an MTM practice and specific patient cases was also queried. A blank space was provided for participants to write in their communication preference. The results were analyzed using descriptive statistics.
Results
A total of 23 primary care physicians participated in one of three focus groups conducted in Pittsburgh (n = 9), York (n = 6), and Philadelphia (n = 8). Participant demographic characteristics are summarized in Table 2 . The majority of participants were male (83%) family medicine (61%) physicians in private practice (91%).
The results of the exit survey are presented in Table 2 . 
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Of 23 participants, 4 (17%) currently work side-by-side with pharmacists to optimize patient care. The majority of participants would like an appointment with a pharmacist to initiate a relationship; however, five physicians preferred not to participate in such a relationship. The preferred method of communication regarding a specific patient was through facsimile.
Thematic analysis results are presented in Table 3 . Detailed findings are described below.
Patient medication-related needs
Common patient medication-related needs across all focus groups included patient adherence, adverse effects, drug interactions, affordability (of medications), and lack of patient understanding toward medication regimens.
Perceived benefits of MtM services
Benefits of MTM were more frequently voiced in the York group compared with the other two groups. The most frequently reported benefit was the complete medication list provided to patient and physician(s). Participants believed that identifying potential medication problems and improving patient adherence to medication regimens were potential benefits.
concerns with MtM
The participants' primary concern was the belief that physicians are better suited to provide MTM because pharmacists 
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would not know the patient as well and may lack necessary clinical training. One physician provided the following description: "There is benefit; I don't think anybody is arguing that point. Nobody is arguing the point that [having] somebody sit down and look through medications is not beneficial, of course it's beneficial. We are questioning very strongly who should be doing it. We feel that we [physicians] should be doing it." Reimbursement issues repeatedly emerged. Physicians wanted reimbursement for time spent working with pharmacists on patient medication issues and questioned how pharmacists would be paid for the service. One physician summarized as follows: "I think a lot of what you're hearing from us [during the focus group session] is that we feel put upon for our time to begin with and reimbursement is low and we don't get reimbursement for phone time and a lot of the things we do. This is more time we have to spend for something that's unreimbursed-it's frustrating."
Physician-pharmacist communication
Participants felt strongly that pharmacists must clearly communicate the benefit of MTM in order to initiate a collaborative relationship; physicians repeatedly stated that they need a clearer understanding of the mechanics of the program and the impact on the patient's care. One physician summarized his lack of comprehension of MTM as follows: "Our paranoia is filling in the gaps here, because we don't know what this looks like. If in other focus groups you would have one of these people [investigators] come in and give a brief description of it or account, or if we would see a video, 5 minutes of what this looked like, I think that might help us in some way critique the situation."
The need for an established, trusting relationship between the pharmacist and physician was repeatedly mentioned. Although MTM can occur in both a community pharmacy and a physician's office, participants expressed a preference for the model of a pharmacist in a physician's office. Participants felt that effective physician-pharmacist communication is essential for MTM to be successful and expressed concern that a communication gap could exist if the pharmacist was off site.
Discussion
An overwhelming finding across all groups was the lack of understanding of MTM by physician participants. The Pittsburgh group was uniquely negative overall because some participants stated false information regarding MTM and other participants reacted to this misinformation. This response emphasizes a need for clear communication about the mechanics of MTM. In the two other groups, physicians wanted more information about MTM. Despite the verbal and written description of MTM, participants requested a video to help them to visualize the process. Pharmacists must clearly explain and/or demonstrate MTM so that physicians can understand how it may work in their practice.
Some participants recognized pharmacists' ability to meet common medication-related needs, especially aiding patients in medication reconciliation and regimen adherence, and perceived a value for their practice. However, with the exception of one group (York), physician participants did not mention that pharmacists could aid in therapeutic decision making. Similarly, published reports have indicated that physicians perceive a benefit in having "checks and balances" for medication safety. 10, 19 Although physicians identified some benefits, many participants felt better suited than pharmacists to serve as an MTM provider, similar to results found in the literature. 9 As the patient's primary care provider, participants felt responsible for the patient's medications and were reluctant to relinquish that duty to another individual.
Participants referred to trusted, hospital-based pharmacist colleagues as "PharmDs" or "clinical pharmacists" and expressed concerns with community-based pharmacists' clinical training. Community pharmacists can overcome this barrier by discussing their training and patient care expertise with physicians. Demonstrating clinical ability and building trust with physicians is suggested in the literature. 18 Physician participants across all groups reported feeling a reimbursement strain. To overcome physician reimbursement concerns, pharmacists must clearly establish that MTM can enhance patient care and enable physicians to see more patients. This finding may support models where both physicians and pharmacists are reimbursed for providing MTM services in a community setting. 20 
Limitations
This study involved primary care physicians from Pennsylvania in the context of its health maintenance organizations, insurance payers, pharmacy law, and medical law; conditions may differ in other states. Participants were in practice on average greater than 20 years. Future research on a broader scope should include generalists and specialists with practices across the country and in various stages of practice.
During the first focus group (Pittsburgh), false information regarding MTM from one participant produced reactions by others. As a result, the other facilitators were trained to respond to participant questions with clear, factual information about MTM. Conducting a beta test may have identified some potential problems and prevented some group inconsistencies.
conclusion
These study results reveal that pharmacists must clearly explain MTM and demonstrate their ability to provide medicationrelated patient care. Pharmacists should discuss the physician-pharmacist relationship in person, detail their clinical training, and demonstrate competence. Community pharmacists may propose a defined trial period to meet with patients in the physician's office. Above all, pharmacists must build a trusting relationship with physicians in order to provide enhanced patient care.
